MetaADEDB 2.0 @ LMMD
docosahexaenoyl-paclitaxel
(LRCZQSDQZJBHAF-PUBGEWHCSA-N)
Structure
SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H]([C@H](c1ccccc1)NC(=O)c1ccccc1)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@@H]([C@]3(C(=O)[C@@H](C(=C1C)C2(C)C)OC(=O)C)C)O)OC(=O)C
Type(s)
Investigational
Molecular Formula:
C69H81NO15
Molecular Weight:
1164.380
Log P:
11.1554
Hydrogen Bond Acceptor:
16
Hydrogen Bond Donor:
3
TPSA:
227.36
CAS Number(s):
199796-52-6
Synonym(s)
1.
docosahexaenoyl-paclitaxel
2.
DHA-paclitaxel
3.
Taxoprexin
4.
docosahexaenoic acid-paclitaxel
External Link(s)
MeSHC528070
PubChem Compound6918473
CHEMBLCHEMBL4297441
DrugBankDB05297
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Diarrhea19521262CTD
2Drug Eruptions19521262CTD
3Exanthema19521262CTD
4Fatigue19521262CTD
5Neoplasm Metastasis19521262CTD
6Neutropenia19521262CTD
7Pain19521262CTD
8melanoma19521262CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.